Global Non-invasive Glucose Monitoring Devices Market

Non-invasive Glucose Monitoring Devices Comprehensive Study by Type (Cardiac Monitoring Devices, Brain Monitoring Devices, Blood Pressure Monitoring Devices, Anesthesia Monitoring Devices, Blood Glucose Monitoring Devices), Application (Cardiology, Neurology, Oncology), Modality (Table-Top Devices, Wearable Devices), End User (Hospitals & Clinics, Diagnostic Centers, Research & Academic Institutes) Players and Region - Global Market Outlook to 2032

Non-invasive Glucose Monitoring Devices Market by XX Submarkets | Forecast Years 2025-2032  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Non-invasive Glucose Monitoring Devices
The non-invasive glucose monitoring device market is an emerging segment within the medical technology industry, focused on developing devices that measure blood glucose levels without requiring skin penetration or blood samples. These devices utilize advanced sensing technologies such as optical spectroscopy, radio frequency, and transdermal biosensors to provide real-time or on-demand glucose readings. The growing prevalence of diabetes and the increasing demand for pain-free, user-friendly glucose monitoring solutions are key drivers of market expansion. Wearable devices, such as smartwatches, rings, and skin patches, dominate this sector, offering continuous glucose monitoring for both diabetic patients and health-conscious consumers. Companies like Abbott, DiaMonTech, and Movano Health are investing in research and development to enhance accuracy and accessibility, while regulatory approvals and strategic partnerships play a crucial role in market growth. Additionally, the availability of over-the-counter (OTC) glucose monitoring devices, such as Abbott’s Lingo, is widening consumer access. North America leads the market due to strong healthcare infrastructure and technological advancements, followed by Europe and Asia-Pacific. As innovation accelerates, non-invasive glucose monitoring is expected to revolutionize diabetes management, making it more convenient and less intrusive, ultimately improving the quality of life for millions of individuals worldwide.

AttributesDetails
Study Period2020-2032
Base Year2024
UnitValue (USD Million)


Non-invasive Glucose Monitoring Devices is highly competitive, with several key players dominating the industry. The market players are focused on developing a variety of features and benefits to meet the needs. Thus, constantly introducing new innovation in processing to meet the changing needs and preferences of consumers. The companies are also planning strategic activities like partnerships, mergers, and acquisitions which will help them to sustain in the market and maintain their competitive edge. Analyst at AMA Research estimates that Global Players will contribute the maximum growth to Global Non-invasive Glucose Monitoring Devices market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Advanced Brain Monitoring (United States), General Electric (GE Healthcare) (United States), Medtronic (Ireland), CNSystems Medizintechnik (Austria), Philips (Philips Healthcare) (Netherlands), Integrity Applications (Israel), OrSense (Israel), Abbott (United States), Tensys Medical (United States) and Omron Healthcare (Japan) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are A&D Medical (United States), Vaso Corporation (United States) and CAS Medical Systems (United States).

Segmentation Overview
AMA Research has segmented the market of Global Non-invasive Glucose Monitoring Devices market by Type (Cardiac Monitoring Devices, Brain Monitoring Devices, Blood Pressure Monitoring Devices, Anesthesia Monitoring Devices and Blood Glucose Monitoring Devices), Application (Cardiology, Neurology and Oncology) and Region.



On the basis of geography, the market of Non-invasive Glucose Monitoring Devices has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Modality, the sub-segment i.e. Table-Top Devices will boost the Non-invasive Glucose Monitoring Devices market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End User, the sub-segment i.e. Hospitals & Clinics will boost the Non-invasive Glucose Monitoring Devices market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Integration with Wearable Technology

Market Growth Drivers:
Increased the demand for non-invasive monitoring solutions and Shift towards telemedicine

Challenges:
High Development Costs

Restraints:
Accuracy Concerns

Opportunities:
Innovations in sensor technology and Data analytics have enhanced the accuracy and reliability of non-invasive devices

Market Leaders and their expansionary development strategies
In May 2023, Planon, a developer of building management software, formed a strategic partnership with SAP. This collaboration aimed to integrate Planon's field service management capabilities with SAP's enterprise solutions, offering clients a unified platform for managing real estate and facilities operations.
In September 2024, Abbott introduced its over-the-counter continuous glucose monitoring system, Lingo, in the U.S. This device features adhesive skin patches that sync with smartphones, providing continuous glucose readings without the need for finger pricks. Lingo is targeted at adults not on insulin therapy and is available in various usage packages, including two-week, four-week, and twelve-week options.


Key Target Audience
Government Authorities, Research and Development, Investors, Venture Capitalist and Third Party Knowledge Providers

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Cardiac Monitoring Devices
  • Brain Monitoring Devices
  • Blood Pressure Monitoring Devices
  • Anesthesia Monitoring Devices
  • Blood Glucose Monitoring Devices
By Application
  • Cardiology
  • Neurology
  • Oncology
By Modality
  • Table-Top Devices
  • Wearable Devices

By End User
  • Hospitals & Clinics
  • Diagnostic Centers
  • Research & Academic Institutes

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increased the demand for non-invasive monitoring solutions
      • 3.2.2. Shift towards telemedicine
    • 3.3. Market Challenges
      • 3.3.1. High Development Costs
    • 3.4. Market Trends
      • 3.4.1. Integration with Wearable Technology
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Non-invasive Glucose Monitoring Devices, by Type, Application, Modality, End User and Region (value) (2019-2024)
    • 5.1. Introduction
    • 5.2. Global Non-invasive Glucose Monitoring Devices (Value)
      • 5.2.1. Global Non-invasive Glucose Monitoring Devices by: Type (Value)
        • 5.2.1.1. Cardiac Monitoring Devices
        • 5.2.1.2. Brain Monitoring Devices
        • 5.2.1.3. Blood Pressure Monitoring Devices
        • 5.2.1.4. Anesthesia Monitoring Devices
        • 5.2.1.5. Blood Glucose Monitoring Devices
      • 5.2.2. Global Non-invasive Glucose Monitoring Devices by: Application (Value)
        • 5.2.2.1. Cardiology
        • 5.2.2.2. Neurology
        • 5.2.2.3. Oncology
      • 5.2.3. Global Non-invasive Glucose Monitoring Devices by: Modality (Value)
        • 5.2.3.1. Table-Top Devices
        • 5.2.3.2. Wearable Devices
      • 5.2.4. Global Non-invasive Glucose Monitoring Devices by: End User (Value)
        • 5.2.4.1. Hospitals & Clinics
        • 5.2.4.2. Diagnostic Centers
        • 5.2.4.3. Research & Academic Institutes
      • 5.2.5. Global Non-invasive Glucose Monitoring Devices Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
  • 6. Non-invasive Glucose Monitoring Devices: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2024)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Advanced Brain Monitoring (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. General Electric (GE Healthcare) (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Medtronic (Ireland)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. CNSystems Medizintechnik (Austria)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Philips (Philips Healthcare) (Netherlands)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Integrity Applications (Israel)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. OrSense (Israel)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Abbott (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Tensys Medical (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Omron Healthcare (Japan)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Non-invasive Glucose Monitoring Devices Sale, by Type, Application, Modality, End User and Region (value) (2027-2032)
    • 7.1. Introduction
    • 7.2. Global Non-invasive Glucose Monitoring Devices (Value)
      • 7.2.1. Global Non-invasive Glucose Monitoring Devices by: Type (Value)
        • 7.2.1.1. Cardiac Monitoring Devices
        • 7.2.1.2. Brain Monitoring Devices
        • 7.2.1.3. Blood Pressure Monitoring Devices
        • 7.2.1.4. Anesthesia Monitoring Devices
        • 7.2.1.5. Blood Glucose Monitoring Devices
      • 7.2.2. Global Non-invasive Glucose Monitoring Devices by: Application (Value)
        • 7.2.2.1. Cardiology
        • 7.2.2.2. Neurology
        • 7.2.2.3. Oncology
      • 7.2.3. Global Non-invasive Glucose Monitoring Devices by: Modality (Value)
        • 7.2.3.1. Table-Top Devices
        • 7.2.3.2. Wearable Devices
      • 7.2.4. Global Non-invasive Glucose Monitoring Devices by: End User (Value)
        • 7.2.4.1. Hospitals & Clinics
        • 7.2.4.2. Diagnostic Centers
        • 7.2.4.3. Research & Academic Institutes
      • 7.2.5. Global Non-invasive Glucose Monitoring Devices Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Non-invasive Glucose Monitoring Devices: by Type(USD Million)
  • Table 2. Non-invasive Glucose Monitoring Devices Cardiac Monitoring Devices , by Region USD Million (2019-2024)
  • Table 3. Non-invasive Glucose Monitoring Devices Brain Monitoring Devices , by Region USD Million (2019-2024)
  • Table 4. Non-invasive Glucose Monitoring Devices Blood Pressure Monitoring Devices , by Region USD Million (2019-2024)
  • Table 5. Non-invasive Glucose Monitoring Devices Anesthesia Monitoring Devices , by Region USD Million (2019-2024)
  • Table 6. Non-invasive Glucose Monitoring Devices Blood Glucose Monitoring Devices , by Region USD Million (2019-2024)
  • Table 7. Non-invasive Glucose Monitoring Devices: by Application(USD Million)
  • Table 8. Non-invasive Glucose Monitoring Devices Cardiology , by Region USD Million (2019-2024)
  • Table 9. Non-invasive Glucose Monitoring Devices Neurology , by Region USD Million (2019-2024)
  • Table 10. Non-invasive Glucose Monitoring Devices Oncology , by Region USD Million (2019-2024)
  • Table 11. Non-invasive Glucose Monitoring Devices: by Modality(USD Million)
  • Table 12. Non-invasive Glucose Monitoring Devices Table-Top Devices , by Region USD Million (2019-2024)
  • Table 13. Non-invasive Glucose Monitoring Devices Wearable Devices , by Region USD Million (2019-2024)
  • Table 14. Non-invasive Glucose Monitoring Devices: by End User(USD Million)
  • Table 15. Non-invasive Glucose Monitoring Devices Hospitals & Clinics , by Region USD Million (2019-2024)
  • Table 16. Non-invasive Glucose Monitoring Devices Diagnostic Centers , by Region USD Million (2019-2024)
  • Table 17. Non-invasive Glucose Monitoring Devices Research & Academic Institutes , by Region USD Million (2019-2024)
  • Table 18. South America Non-invasive Glucose Monitoring Devices, by Country USD Million (2019-2024)
  • Table 19. South America Non-invasive Glucose Monitoring Devices, by Type USD Million (2019-2024)
  • Table 20. South America Non-invasive Glucose Monitoring Devices, by Application USD Million (2019-2024)
  • Table 21. South America Non-invasive Glucose Monitoring Devices, by Modality USD Million (2019-2024)
  • Table 22. South America Non-invasive Glucose Monitoring Devices, by End User USD Million (2019-2024)
  • Table 23. Brazil Non-invasive Glucose Monitoring Devices, by Type USD Million (2019-2024)
  • Table 24. Brazil Non-invasive Glucose Monitoring Devices, by Application USD Million (2019-2024)
  • Table 25. Brazil Non-invasive Glucose Monitoring Devices, by Modality USD Million (2019-2024)
  • Table 26. Brazil Non-invasive Glucose Monitoring Devices, by End User USD Million (2019-2024)
  • Table 27. Argentina Non-invasive Glucose Monitoring Devices, by Type USD Million (2019-2024)
  • Table 28. Argentina Non-invasive Glucose Monitoring Devices, by Application USD Million (2019-2024)
  • Table 29. Argentina Non-invasive Glucose Monitoring Devices, by Modality USD Million (2019-2024)
  • Table 30. Argentina Non-invasive Glucose Monitoring Devices, by End User USD Million (2019-2024)
  • Table 31. Rest of South America Non-invasive Glucose Monitoring Devices, by Type USD Million (2019-2024)
  • Table 32. Rest of South America Non-invasive Glucose Monitoring Devices, by Application USD Million (2019-2024)
  • Table 33. Rest of South America Non-invasive Glucose Monitoring Devices, by Modality USD Million (2019-2024)
  • Table 34. Rest of South America Non-invasive Glucose Monitoring Devices, by End User USD Million (2019-2024)
  • Table 35. Asia Pacific Non-invasive Glucose Monitoring Devices, by Country USD Million (2019-2024)
  • Table 36. Asia Pacific Non-invasive Glucose Monitoring Devices, by Type USD Million (2019-2024)
  • Table 37. Asia Pacific Non-invasive Glucose Monitoring Devices, by Application USD Million (2019-2024)
  • Table 38. Asia Pacific Non-invasive Glucose Monitoring Devices, by Modality USD Million (2019-2024)
  • Table 39. Asia Pacific Non-invasive Glucose Monitoring Devices, by End User USD Million (2019-2024)
  • Table 40. China Non-invasive Glucose Monitoring Devices, by Type USD Million (2019-2024)
  • Table 41. China Non-invasive Glucose Monitoring Devices, by Application USD Million (2019-2024)
  • Table 42. China Non-invasive Glucose Monitoring Devices, by Modality USD Million (2019-2024)
  • Table 43. China Non-invasive Glucose Monitoring Devices, by End User USD Million (2019-2024)
  • Table 44. Japan Non-invasive Glucose Monitoring Devices, by Type USD Million (2019-2024)
  • Table 45. Japan Non-invasive Glucose Monitoring Devices, by Application USD Million (2019-2024)
  • Table 46. Japan Non-invasive Glucose Monitoring Devices, by Modality USD Million (2019-2024)
  • Table 47. Japan Non-invasive Glucose Monitoring Devices, by End User USD Million (2019-2024)
  • Table 48. India Non-invasive Glucose Monitoring Devices, by Type USD Million (2019-2024)
  • Table 49. India Non-invasive Glucose Monitoring Devices, by Application USD Million (2019-2024)
  • Table 50. India Non-invasive Glucose Monitoring Devices, by Modality USD Million (2019-2024)
  • Table 51. India Non-invasive Glucose Monitoring Devices, by End User USD Million (2019-2024)
  • Table 52. South Korea Non-invasive Glucose Monitoring Devices, by Type USD Million (2019-2024)
  • Table 53. South Korea Non-invasive Glucose Monitoring Devices, by Application USD Million (2019-2024)
  • Table 54. South Korea Non-invasive Glucose Monitoring Devices, by Modality USD Million (2019-2024)
  • Table 55. South Korea Non-invasive Glucose Monitoring Devices, by End User USD Million (2019-2024)
  • Table 56. Taiwan Non-invasive Glucose Monitoring Devices, by Type USD Million (2019-2024)
  • Table 57. Taiwan Non-invasive Glucose Monitoring Devices, by Application USD Million (2019-2024)
  • Table 58. Taiwan Non-invasive Glucose Monitoring Devices, by Modality USD Million (2019-2024)
  • Table 59. Taiwan Non-invasive Glucose Monitoring Devices, by End User USD Million (2019-2024)
  • Table 60. Australia Non-invasive Glucose Monitoring Devices, by Type USD Million (2019-2024)
  • Table 61. Australia Non-invasive Glucose Monitoring Devices, by Application USD Million (2019-2024)
  • Table 62. Australia Non-invasive Glucose Monitoring Devices, by Modality USD Million (2019-2024)
  • Table 63. Australia Non-invasive Glucose Monitoring Devices, by End User USD Million (2019-2024)
  • Table 64. Rest of Asia-Pacific Non-invasive Glucose Monitoring Devices, by Type USD Million (2019-2024)
  • Table 65. Rest of Asia-Pacific Non-invasive Glucose Monitoring Devices, by Application USD Million (2019-2024)
  • Table 66. Rest of Asia-Pacific Non-invasive Glucose Monitoring Devices, by Modality USD Million (2019-2024)
  • Table 67. Rest of Asia-Pacific Non-invasive Glucose Monitoring Devices, by End User USD Million (2019-2024)
  • Table 68. Europe Non-invasive Glucose Monitoring Devices, by Country USD Million (2019-2024)
  • Table 69. Europe Non-invasive Glucose Monitoring Devices, by Type USD Million (2019-2024)
  • Table 70. Europe Non-invasive Glucose Monitoring Devices, by Application USD Million (2019-2024)
  • Table 71. Europe Non-invasive Glucose Monitoring Devices, by Modality USD Million (2019-2024)
  • Table 72. Europe Non-invasive Glucose Monitoring Devices, by End User USD Million (2019-2024)
  • Table 73. Germany Non-invasive Glucose Monitoring Devices, by Type USD Million (2019-2024)
  • Table 74. Germany Non-invasive Glucose Monitoring Devices, by Application USD Million (2019-2024)
  • Table 75. Germany Non-invasive Glucose Monitoring Devices, by Modality USD Million (2019-2024)
  • Table 76. Germany Non-invasive Glucose Monitoring Devices, by End User USD Million (2019-2024)
  • Table 77. France Non-invasive Glucose Monitoring Devices, by Type USD Million (2019-2024)
  • Table 78. France Non-invasive Glucose Monitoring Devices, by Application USD Million (2019-2024)
  • Table 79. France Non-invasive Glucose Monitoring Devices, by Modality USD Million (2019-2024)
  • Table 80. France Non-invasive Glucose Monitoring Devices, by End User USD Million (2019-2024)
  • Table 81. Italy Non-invasive Glucose Monitoring Devices, by Type USD Million (2019-2024)
  • Table 82. Italy Non-invasive Glucose Monitoring Devices, by Application USD Million (2019-2024)
  • Table 83. Italy Non-invasive Glucose Monitoring Devices, by Modality USD Million (2019-2024)
  • Table 84. Italy Non-invasive Glucose Monitoring Devices, by End User USD Million (2019-2024)
  • Table 85. United Kingdom Non-invasive Glucose Monitoring Devices, by Type USD Million (2019-2024)
  • Table 86. United Kingdom Non-invasive Glucose Monitoring Devices, by Application USD Million (2019-2024)
  • Table 87. United Kingdom Non-invasive Glucose Monitoring Devices, by Modality USD Million (2019-2024)
  • Table 88. United Kingdom Non-invasive Glucose Monitoring Devices, by End User USD Million (2019-2024)
  • Table 89. Netherlands Non-invasive Glucose Monitoring Devices, by Type USD Million (2019-2024)
  • Table 90. Netherlands Non-invasive Glucose Monitoring Devices, by Application USD Million (2019-2024)
  • Table 91. Netherlands Non-invasive Glucose Monitoring Devices, by Modality USD Million (2019-2024)
  • Table 92. Netherlands Non-invasive Glucose Monitoring Devices, by End User USD Million (2019-2024)
  • Table 93. Rest of Europe Non-invasive Glucose Monitoring Devices, by Type USD Million (2019-2024)
  • Table 94. Rest of Europe Non-invasive Glucose Monitoring Devices, by Application USD Million (2019-2024)
  • Table 95. Rest of Europe Non-invasive Glucose Monitoring Devices, by Modality USD Million (2019-2024)
  • Table 96. Rest of Europe Non-invasive Glucose Monitoring Devices, by End User USD Million (2019-2024)
  • Table 97. MEA Non-invasive Glucose Monitoring Devices, by Country USD Million (2019-2024)
  • Table 98. MEA Non-invasive Glucose Monitoring Devices, by Type USD Million (2019-2024)
  • Table 99. MEA Non-invasive Glucose Monitoring Devices, by Application USD Million (2019-2024)
  • Table 100. MEA Non-invasive Glucose Monitoring Devices, by Modality USD Million (2019-2024)
  • Table 101. MEA Non-invasive Glucose Monitoring Devices, by End User USD Million (2019-2024)
  • Table 102. Middle East Non-invasive Glucose Monitoring Devices, by Type USD Million (2019-2024)
  • Table 103. Middle East Non-invasive Glucose Monitoring Devices, by Application USD Million (2019-2024)
  • Table 104. Middle East Non-invasive Glucose Monitoring Devices, by Modality USD Million (2019-2024)
  • Table 105. Middle East Non-invasive Glucose Monitoring Devices, by End User USD Million (2019-2024)
  • Table 106. Africa Non-invasive Glucose Monitoring Devices, by Type USD Million (2019-2024)
  • Table 107. Africa Non-invasive Glucose Monitoring Devices, by Application USD Million (2019-2024)
  • Table 108. Africa Non-invasive Glucose Monitoring Devices, by Modality USD Million (2019-2024)
  • Table 109. Africa Non-invasive Glucose Monitoring Devices, by End User USD Million (2019-2024)
  • Table 110. North America Non-invasive Glucose Monitoring Devices, by Country USD Million (2019-2024)
  • Table 111. North America Non-invasive Glucose Monitoring Devices, by Type USD Million (2019-2024)
  • Table 112. North America Non-invasive Glucose Monitoring Devices, by Application USD Million (2019-2024)
  • Table 113. North America Non-invasive Glucose Monitoring Devices, by Modality USD Million (2019-2024)
  • Table 114. North America Non-invasive Glucose Monitoring Devices, by End User USD Million (2019-2024)
  • Table 115. United States Non-invasive Glucose Monitoring Devices, by Type USD Million (2019-2024)
  • Table 116. United States Non-invasive Glucose Monitoring Devices, by Application USD Million (2019-2024)
  • Table 117. United States Non-invasive Glucose Monitoring Devices, by Modality USD Million (2019-2024)
  • Table 118. United States Non-invasive Glucose Monitoring Devices, by End User USD Million (2019-2024)
  • Table 119. Canada Non-invasive Glucose Monitoring Devices, by Type USD Million (2019-2024)
  • Table 120. Canada Non-invasive Glucose Monitoring Devices, by Application USD Million (2019-2024)
  • Table 121. Canada Non-invasive Glucose Monitoring Devices, by Modality USD Million (2019-2024)
  • Table 122. Canada Non-invasive Glucose Monitoring Devices, by End User USD Million (2019-2024)
  • Table 123. Mexico Non-invasive Glucose Monitoring Devices, by Type USD Million (2019-2024)
  • Table 124. Mexico Non-invasive Glucose Monitoring Devices, by Application USD Million (2019-2024)
  • Table 125. Mexico Non-invasive Glucose Monitoring Devices, by Modality USD Million (2019-2024)
  • Table 126. Mexico Non-invasive Glucose Monitoring Devices, by End User USD Million (2019-2024)
  • Table 127. Company Basic Information, Sales Area and Its Competitors
  • Table 128. Company Basic Information, Sales Area and Its Competitors
  • Table 129. Company Basic Information, Sales Area and Its Competitors
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Non-invasive Glucose Monitoring Devices: by Type(USD Million)
  • Table 138. Non-invasive Glucose Monitoring Devices Cardiac Monitoring Devices , by Region USD Million (2027-2032)
  • Table 139. Non-invasive Glucose Monitoring Devices Brain Monitoring Devices , by Region USD Million (2027-2032)
  • Table 140. Non-invasive Glucose Monitoring Devices Blood Pressure Monitoring Devices , by Region USD Million (2027-2032)
  • Table 141. Non-invasive Glucose Monitoring Devices Anesthesia Monitoring Devices , by Region USD Million (2027-2032)
  • Table 142. Non-invasive Glucose Monitoring Devices Blood Glucose Monitoring Devices , by Region USD Million (2027-2032)
  • Table 143. Non-invasive Glucose Monitoring Devices: by Application(USD Million)
  • Table 144. Non-invasive Glucose Monitoring Devices Cardiology , by Region USD Million (2027-2032)
  • Table 145. Non-invasive Glucose Monitoring Devices Neurology , by Region USD Million (2027-2032)
  • Table 146. Non-invasive Glucose Monitoring Devices Oncology , by Region USD Million (2027-2032)
  • Table 147. Non-invasive Glucose Monitoring Devices: by Modality(USD Million)
  • Table 148. Non-invasive Glucose Monitoring Devices Table-Top Devices , by Region USD Million (2027-2032)
  • Table 149. Non-invasive Glucose Monitoring Devices Wearable Devices , by Region USD Million (2027-2032)
  • Table 150. Non-invasive Glucose Monitoring Devices: by End User(USD Million)
  • Table 151. Non-invasive Glucose Monitoring Devices Hospitals & Clinics , by Region USD Million (2027-2032)
  • Table 152. Non-invasive Glucose Monitoring Devices Diagnostic Centers , by Region USD Million (2027-2032)
  • Table 153. Non-invasive Glucose Monitoring Devices Research & Academic Institutes , by Region USD Million (2027-2032)
  • Table 154. South America Non-invasive Glucose Monitoring Devices, by Country USD Million (2027-2032)
  • Table 155. South America Non-invasive Glucose Monitoring Devices, by Type USD Million (2027-2032)
  • Table 156. South America Non-invasive Glucose Monitoring Devices, by Application USD Million (2027-2032)
  • Table 157. South America Non-invasive Glucose Monitoring Devices, by Modality USD Million (2027-2032)
  • Table 158. South America Non-invasive Glucose Monitoring Devices, by End User USD Million (2027-2032)
  • Table 159. Brazil Non-invasive Glucose Monitoring Devices, by Type USD Million (2027-2032)
  • Table 160. Brazil Non-invasive Glucose Monitoring Devices, by Application USD Million (2027-2032)
  • Table 161. Brazil Non-invasive Glucose Monitoring Devices, by Modality USD Million (2027-2032)
  • Table 162. Brazil Non-invasive Glucose Monitoring Devices, by End User USD Million (2027-2032)
  • Table 163. Argentina Non-invasive Glucose Monitoring Devices, by Type USD Million (2027-2032)
  • Table 164. Argentina Non-invasive Glucose Monitoring Devices, by Application USD Million (2027-2032)
  • Table 165. Argentina Non-invasive Glucose Monitoring Devices, by Modality USD Million (2027-2032)
  • Table 166. Argentina Non-invasive Glucose Monitoring Devices, by End User USD Million (2027-2032)
  • Table 167. Rest of South America Non-invasive Glucose Monitoring Devices, by Type USD Million (2027-2032)
  • Table 168. Rest of South America Non-invasive Glucose Monitoring Devices, by Application USD Million (2027-2032)
  • Table 169. Rest of South America Non-invasive Glucose Monitoring Devices, by Modality USD Million (2027-2032)
  • Table 170. Rest of South America Non-invasive Glucose Monitoring Devices, by End User USD Million (2027-2032)
  • Table 171. Asia Pacific Non-invasive Glucose Monitoring Devices, by Country USD Million (2027-2032)
  • Table 172. Asia Pacific Non-invasive Glucose Monitoring Devices, by Type USD Million (2027-2032)
  • Table 173. Asia Pacific Non-invasive Glucose Monitoring Devices, by Application USD Million (2027-2032)
  • Table 174. Asia Pacific Non-invasive Glucose Monitoring Devices, by Modality USD Million (2027-2032)
  • Table 175. Asia Pacific Non-invasive Glucose Monitoring Devices, by End User USD Million (2027-2032)
  • Table 176. China Non-invasive Glucose Monitoring Devices, by Type USD Million (2027-2032)
  • Table 177. China Non-invasive Glucose Monitoring Devices, by Application USD Million (2027-2032)
  • Table 178. China Non-invasive Glucose Monitoring Devices, by Modality USD Million (2027-2032)
  • Table 179. China Non-invasive Glucose Monitoring Devices, by End User USD Million (2027-2032)
  • Table 180. Japan Non-invasive Glucose Monitoring Devices, by Type USD Million (2027-2032)
  • Table 181. Japan Non-invasive Glucose Monitoring Devices, by Application USD Million (2027-2032)
  • Table 182. Japan Non-invasive Glucose Monitoring Devices, by Modality USD Million (2027-2032)
  • Table 183. Japan Non-invasive Glucose Monitoring Devices, by End User USD Million (2027-2032)
  • Table 184. India Non-invasive Glucose Monitoring Devices, by Type USD Million (2027-2032)
  • Table 185. India Non-invasive Glucose Monitoring Devices, by Application USD Million (2027-2032)
  • Table 186. India Non-invasive Glucose Monitoring Devices, by Modality USD Million (2027-2032)
  • Table 187. India Non-invasive Glucose Monitoring Devices, by End User USD Million (2027-2032)
  • Table 188. South Korea Non-invasive Glucose Monitoring Devices, by Type USD Million (2027-2032)
  • Table 189. South Korea Non-invasive Glucose Monitoring Devices, by Application USD Million (2027-2032)
  • Table 190. South Korea Non-invasive Glucose Monitoring Devices, by Modality USD Million (2027-2032)
  • Table 191. South Korea Non-invasive Glucose Monitoring Devices, by End User USD Million (2027-2032)
  • Table 192. Taiwan Non-invasive Glucose Monitoring Devices, by Type USD Million (2027-2032)
  • Table 193. Taiwan Non-invasive Glucose Monitoring Devices, by Application USD Million (2027-2032)
  • Table 194. Taiwan Non-invasive Glucose Monitoring Devices, by Modality USD Million (2027-2032)
  • Table 195. Taiwan Non-invasive Glucose Monitoring Devices, by End User USD Million (2027-2032)
  • Table 196. Australia Non-invasive Glucose Monitoring Devices, by Type USD Million (2027-2032)
  • Table 197. Australia Non-invasive Glucose Monitoring Devices, by Application USD Million (2027-2032)
  • Table 198. Australia Non-invasive Glucose Monitoring Devices, by Modality USD Million (2027-2032)
  • Table 199. Australia Non-invasive Glucose Monitoring Devices, by End User USD Million (2027-2032)
  • Table 200. Rest of Asia-Pacific Non-invasive Glucose Monitoring Devices, by Type USD Million (2027-2032)
  • Table 201. Rest of Asia-Pacific Non-invasive Glucose Monitoring Devices, by Application USD Million (2027-2032)
  • Table 202. Rest of Asia-Pacific Non-invasive Glucose Monitoring Devices, by Modality USD Million (2027-2032)
  • Table 203. Rest of Asia-Pacific Non-invasive Glucose Monitoring Devices, by End User USD Million (2027-2032)
  • Table 204. Europe Non-invasive Glucose Monitoring Devices, by Country USD Million (2027-2032)
  • Table 205. Europe Non-invasive Glucose Monitoring Devices, by Type USD Million (2027-2032)
  • Table 206. Europe Non-invasive Glucose Monitoring Devices, by Application USD Million (2027-2032)
  • Table 207. Europe Non-invasive Glucose Monitoring Devices, by Modality USD Million (2027-2032)
  • Table 208. Europe Non-invasive Glucose Monitoring Devices, by End User USD Million (2027-2032)
  • Table 209. Germany Non-invasive Glucose Monitoring Devices, by Type USD Million (2027-2032)
  • Table 210. Germany Non-invasive Glucose Monitoring Devices, by Application USD Million (2027-2032)
  • Table 211. Germany Non-invasive Glucose Monitoring Devices, by Modality USD Million (2027-2032)
  • Table 212. Germany Non-invasive Glucose Monitoring Devices, by End User USD Million (2027-2032)
  • Table 213. France Non-invasive Glucose Monitoring Devices, by Type USD Million (2027-2032)
  • Table 214. France Non-invasive Glucose Monitoring Devices, by Application USD Million (2027-2032)
  • Table 215. France Non-invasive Glucose Monitoring Devices, by Modality USD Million (2027-2032)
  • Table 216. France Non-invasive Glucose Monitoring Devices, by End User USD Million (2027-2032)
  • Table 217. Italy Non-invasive Glucose Monitoring Devices, by Type USD Million (2027-2032)
  • Table 218. Italy Non-invasive Glucose Monitoring Devices, by Application USD Million (2027-2032)
  • Table 219. Italy Non-invasive Glucose Monitoring Devices, by Modality USD Million (2027-2032)
  • Table 220. Italy Non-invasive Glucose Monitoring Devices, by End User USD Million (2027-2032)
  • Table 221. United Kingdom Non-invasive Glucose Monitoring Devices, by Type USD Million (2027-2032)
  • Table 222. United Kingdom Non-invasive Glucose Monitoring Devices, by Application USD Million (2027-2032)
  • Table 223. United Kingdom Non-invasive Glucose Monitoring Devices, by Modality USD Million (2027-2032)
  • Table 224. United Kingdom Non-invasive Glucose Monitoring Devices, by End User USD Million (2027-2032)
  • Table 225. Netherlands Non-invasive Glucose Monitoring Devices, by Type USD Million (2027-2032)
  • Table 226. Netherlands Non-invasive Glucose Monitoring Devices, by Application USD Million (2027-2032)
  • Table 227. Netherlands Non-invasive Glucose Monitoring Devices, by Modality USD Million (2027-2032)
  • Table 228. Netherlands Non-invasive Glucose Monitoring Devices, by End User USD Million (2027-2032)
  • Table 229. Rest of Europe Non-invasive Glucose Monitoring Devices, by Type USD Million (2027-2032)
  • Table 230. Rest of Europe Non-invasive Glucose Monitoring Devices, by Application USD Million (2027-2032)
  • Table 231. Rest of Europe Non-invasive Glucose Monitoring Devices, by Modality USD Million (2027-2032)
  • Table 232. Rest of Europe Non-invasive Glucose Monitoring Devices, by End User USD Million (2027-2032)
  • Table 233. MEA Non-invasive Glucose Monitoring Devices, by Country USD Million (2027-2032)
  • Table 234. MEA Non-invasive Glucose Monitoring Devices, by Type USD Million (2027-2032)
  • Table 235. MEA Non-invasive Glucose Monitoring Devices, by Application USD Million (2027-2032)
  • Table 236. MEA Non-invasive Glucose Monitoring Devices, by Modality USD Million (2027-2032)
  • Table 237. MEA Non-invasive Glucose Monitoring Devices, by End User USD Million (2027-2032)
  • Table 238. Middle East Non-invasive Glucose Monitoring Devices, by Type USD Million (2027-2032)
  • Table 239. Middle East Non-invasive Glucose Monitoring Devices, by Application USD Million (2027-2032)
  • Table 240. Middle East Non-invasive Glucose Monitoring Devices, by Modality USD Million (2027-2032)
  • Table 241. Middle East Non-invasive Glucose Monitoring Devices, by End User USD Million (2027-2032)
  • Table 242. Africa Non-invasive Glucose Monitoring Devices, by Type USD Million (2027-2032)
  • Table 243. Africa Non-invasive Glucose Monitoring Devices, by Application USD Million (2027-2032)
  • Table 244. Africa Non-invasive Glucose Monitoring Devices, by Modality USD Million (2027-2032)
  • Table 245. Africa Non-invasive Glucose Monitoring Devices, by End User USD Million (2027-2032)
  • Table 246. North America Non-invasive Glucose Monitoring Devices, by Country USD Million (2027-2032)
  • Table 247. North America Non-invasive Glucose Monitoring Devices, by Type USD Million (2027-2032)
  • Table 248. North America Non-invasive Glucose Monitoring Devices, by Application USD Million (2027-2032)
  • Table 249. North America Non-invasive Glucose Monitoring Devices, by Modality USD Million (2027-2032)
  • Table 250. North America Non-invasive Glucose Monitoring Devices, by End User USD Million (2027-2032)
  • Table 251. United States Non-invasive Glucose Monitoring Devices, by Type USD Million (2027-2032)
  • Table 252. United States Non-invasive Glucose Monitoring Devices, by Application USD Million (2027-2032)
  • Table 253. United States Non-invasive Glucose Monitoring Devices, by Modality USD Million (2027-2032)
  • Table 254. United States Non-invasive Glucose Monitoring Devices, by End User USD Million (2027-2032)
  • Table 255. Canada Non-invasive Glucose Monitoring Devices, by Type USD Million (2027-2032)
  • Table 256. Canada Non-invasive Glucose Monitoring Devices, by Application USD Million (2027-2032)
  • Table 257. Canada Non-invasive Glucose Monitoring Devices, by Modality USD Million (2027-2032)
  • Table 258. Canada Non-invasive Glucose Monitoring Devices, by End User USD Million (2027-2032)
  • Table 259. Mexico Non-invasive Glucose Monitoring Devices, by Type USD Million (2027-2032)
  • Table 260. Mexico Non-invasive Glucose Monitoring Devices, by Application USD Million (2027-2032)
  • Table 261. Mexico Non-invasive Glucose Monitoring Devices, by Modality USD Million (2027-2032)
  • Table 262. Mexico Non-invasive Glucose Monitoring Devices, by End User USD Million (2027-2032)
  • Table 263. Research Programs/Design for This Report
  • Table 264. Key Data Information from Secondary Sources
  • Table 265. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Non-invasive Glucose Monitoring Devices: by Type USD Million (2019-2024)
  • Figure 5. Global Non-invasive Glucose Monitoring Devices: by Application USD Million (2019-2024)
  • Figure 6. Global Non-invasive Glucose Monitoring Devices: by Modality USD Million (2019-2024)
  • Figure 7. Global Non-invasive Glucose Monitoring Devices: by End User USD Million (2019-2024)
  • Figure 8. South America Non-invasive Glucose Monitoring Devices Share (%), by Country
  • Figure 9. Asia Pacific Non-invasive Glucose Monitoring Devices Share (%), by Country
  • Figure 10. Europe Non-invasive Glucose Monitoring Devices Share (%), by Country
  • Figure 11. MEA Non-invasive Glucose Monitoring Devices Share (%), by Country
  • Figure 12. North America Non-invasive Glucose Monitoring Devices Share (%), by Country
  • Figure 13. Global Non-invasive Glucose Monitoring Devices share by Players 2024 (%)
  • Figure 14. Global Non-invasive Glucose Monitoring Devices share by Players (Top 3) 2024(%)
  • Figure 15. Global Non-invasive Glucose Monitoring Devices share by Players (Top 5) 2024(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Advanced Brain Monitoring (United States) Revenue, Net Income and Gross profit
  • Figure 18. Advanced Brain Monitoring (United States) Revenue: by Geography 2024
  • Figure 19. General Electric (GE Healthcare) (United States) Revenue, Net Income and Gross profit
  • Figure 20. General Electric (GE Healthcare) (United States) Revenue: by Geography 2024
  • Figure 21. Medtronic (Ireland) Revenue, Net Income and Gross profit
  • Figure 22. Medtronic (Ireland) Revenue: by Geography 2024
  • Figure 23. CNSystems Medizintechnik (Austria) Revenue, Net Income and Gross profit
  • Figure 24. CNSystems Medizintechnik (Austria) Revenue: by Geography 2024
  • Figure 25. Philips (Philips Healthcare) (Netherlands) Revenue, Net Income and Gross profit
  • Figure 26. Philips (Philips Healthcare) (Netherlands) Revenue: by Geography 2024
  • Figure 27. Integrity Applications (Israel) Revenue, Net Income and Gross profit
  • Figure 28. Integrity Applications (Israel) Revenue: by Geography 2024
  • Figure 29. OrSense (Israel) Revenue, Net Income and Gross profit
  • Figure 30. OrSense (Israel) Revenue: by Geography 2024
  • Figure 31. Abbott (United States) Revenue, Net Income and Gross profit
  • Figure 32. Abbott (United States) Revenue: by Geography 2024
  • Figure 33. Tensys Medical (United States) Revenue, Net Income and Gross profit
  • Figure 34. Tensys Medical (United States) Revenue: by Geography 2024
  • Figure 35. Omron Healthcare (Japan) Revenue, Net Income and Gross profit
  • Figure 36. Omron Healthcare (Japan) Revenue: by Geography 2024
  • Figure 37. Global Non-invasive Glucose Monitoring Devices: by Type USD Million (2027-2032)
  • Figure 38. Global Non-invasive Glucose Monitoring Devices: by Application USD Million (2027-2032)
  • Figure 39. Global Non-invasive Glucose Monitoring Devices: by Modality USD Million (2027-2032)
  • Figure 40. Global Non-invasive Glucose Monitoring Devices: by End User USD Million (2027-2032)
  • Figure 41. South America Non-invasive Glucose Monitoring Devices Share (%), by Country
  • Figure 42. Asia Pacific Non-invasive Glucose Monitoring Devices Share (%), by Country
  • Figure 43. Europe Non-invasive Glucose Monitoring Devices Share (%), by Country
  • Figure 44. MEA Non-invasive Glucose Monitoring Devices Share (%), by Country
  • Figure 45. North America Non-invasive Glucose Monitoring Devices Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Advanced Brain Monitoring (United States)
  • General Electric (GE Healthcare) (United States)
  • Medtronic (Ireland)
  • CNSystems Medizintechnik (Austria)
  • Philips (Philips Healthcare) (Netherlands)
  • Integrity Applications (Israel)
  • OrSense (Israel)
  • Abbott (United States)
  • Tensys Medical (United States)
  • Omron Healthcare (Japan)
Additional players considered in the study are as follows:
A&D Medical (United States) , Vaso Corporation (United States) , CAS Medical Systems (United States)
Select User Access Type

Key Highlights of Report


Mar 2025 204 Pages 74 Tables Base Year: 2024 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Non-invasive Glucose Monitoring Devices Market Quantitative research analysis
Global Non-invasive Glucose Monitoring Devices Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Advanced Brain Monitoring (United States), General Electric (GE Healthcare) (United States), Medtronic (Ireland), CNSystems Medizintechnik (Austria), Philips (Philips Healthcare) (Netherlands), Integrity Applications (Israel), OrSense (Israel), Abbott (United States), Tensys Medical (United States) and Omron Healthcare (Japan) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Integration with Wearable Technology" is seen as one of major influencing trends for Non-invasive Glucose Monitoring Devices Market during projected period 2024-2032.
The Non-invasive Glucose Monitoring Devices market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Non-invasive Glucose Monitoring Devices Market Report?

Have a Query? Click Here

Other Related Reports

Dental Block Comprehensive Study by Type (Resin-Based, Zirconia-Reinforced Nano-Ceramic, Hybrid Ceramic), Application (Inlays and Onlays, Dental Crowns, Dental Bridges, Dentures), Translucency Type (...
$ 3750
Aerosol Delivery Devices Comprehensive Study by Type (Small-Volume Nebulize, Pressurized Metered-Dose Inhaler, Dry-Powder Inhaler), Application (Asthma, Chronic Obstructive Pulmonary Disease (COPD), ...
$ 3750
Fully-Automatic External Defibrillators Comprehensive Study by Type (Non-synchronous Defibrillator, Synchronous Defibrillator), Application (Hospitals, Public Access, Home, Training, Others), Sales C...
$ 3350
Dna Gel Imager Comprehensive Study by Type (Normal Gel Imaging Analysis System, Chemiluminescence Imaging Analysis System, Multicolor Fluorescence Imaging Analysis System, Others), Application (Molec...
$ 3750
Operating Room Equipment Comprehensive Study by Type (Anesthesia Machines, Patient Monitors, Endoscopy Equipment, Lights-Surgical, Surgical Imaging Devices, Surgical Tables, Respiratory Ventilators, ...
$ 3750
Medical Air Disinfection Machine Comprehensive Study by Type (Germs and Bacteria, Dust Collectors, Fume and Smoke Collectors, Others), Application (Hospital, Clinic, Others), Distribution Channel (Of...
$ 3450